Thomson Reuters Journals are available through the BioMed Central platform and feature high quality reviews as well as paper, patent and web alerts to provide accurate and timely information on developments in drug R&D. Covering over 400 scientific meetings per year as well as the most important developments in their subject areas, the Thomson Reuters Journals provide a practical way of staying on top of the latest developments.

Current Opinion in Molecular Therapeutics provides a broad and clearly defined coverage of all major areas of research in the field of molecular medicine, covering:

• Topics suggested by our wide Editorial Board
• Comment on the latest discoveries
• Opinions on the latest disclosures in scientific literature